CTOs on the Move

Shore Memorial Hospital

www.shorememorial.org

 
Shore Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Somers Point, NJ. To find more information about Shore Memorial Hospital, please visit www.shorememorial.org
  • Number of Employees: 0-25
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

High Point Regional Health System

As a not-for-profit Health System governed by a volunteer, community-based board of trustees, High Point Regional offers a wide variety of inpatient and outpatient care.

AgilityHealth

AgilityHealth® offers the world`s leading measurement and continuous improvement platform designed to accelerate the enterprise business agility journey and make `New Ways of Work` a reality - not just a statement. We`re passionate about turning data and insights into action, enabling teams to help themselves grow so organizations can scale and sustain the change. AgilityHealth brings together the three metrics that matter: Maturity, Performance and Outcomes. Plus, our AgileVideos platform enables digital and Agile talent development at scale with short on-demand videos.

Microlife Usa

Microlife Usa is a Dunedin, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Spectrum Health Systems

Spectrum Health Systems is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.